Laura Claire Reed

Laura Claire Reed is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that modulate tumor necrosis factor (TNF) activity. Her work is crucial in addressing various human ailments, including autoimmune and inflammatory disorders.

Latest Patents

Laura holds a patent for "Imidazopyridine derivatives as modulators of TNF activity." This patent describes a series of imidazo[1,2-a]pyridine derivatives that serve as potent modulators of human TNFα activity. These compounds are beneficial in the treatment and prevention of a wide range of disorders, including neurological, cardiovascular, metabolic, ocular, and oncological conditions.

Career Highlights

Laura is currently employed at UCB Biopharma Sprl, where she continues to innovate and develop new therapeutic solutions. Her expertise in pharmacology and medicinal chemistry has positioned her as a key player in her field.

Collaborations

Throughout her career, Laura has collaborated with notable colleagues, including Jonathan Bentley and Daniel Christopher Brookings. These partnerships have enhanced her research and contributed to the advancement of her projects.

Conclusion

Laura Claire Reed's work in developing imidazopyridine derivatives showcases her commitment to improving human health through innovative solutions. Her contributions to the field of biopharmaceuticals are invaluable and continue to pave the way for future advancements.

Profile summary based on public USPTO records.